Cardiac Damage and Conduction Disorders after Transcatheter Aortic Valve Implantation

Recently, a staging system using 4 grades has been proposed to quantify the extent of cardiac damage associated with aortic stenosis (AS), namely AS-related cardiac damage staging (ASCDS). ASCDS is independently associated with all-cause mortality and important clinical outcomes. To evaluate whether...

Full description

Bibliographic Details
Main Authors: François Damas, Mai-Linh Nguyen Trung, Adriana Postolache, Hélène Petitjean, Mathieu Lempereur, Tommaso Viva, Cécile Oury, Raluca Dulgheru, Patrizio Lancellotti
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/13/2/409
Description
Summary:Recently, a staging system using 4 grades has been proposed to quantify the extent of cardiac damage associated with aortic stenosis (AS), namely AS-related cardiac damage staging (ASCDS). ASCDS is independently associated with all-cause mortality and important clinical outcomes. To evaluate whether it might be associated with the occurrence of conduction system disorders after TAVI, a total of 119 symptomatic patients with severe AS who underwent a TAVI were categorized according to ASCDS: group 1 (13.5%): no or LV damage; group 2 (58.8%): left atrial/mitral valve damage, atrial fibrillation (AF); group 3 (27.7%): low-flow state, pulmonary vasculature/tricuspid valve/RV damage. After TAVI, 34% of patients exhibited LBBB and 10% high-degree atrioventricular block (HD-AVB). No patient in group 1 developed HD-AVB whereas new LBBB was frequent in groups 2 and 3. Twenty-one patients presented with paroxysmal AF with a higher rate for each group increment (group 1: <i>n</i> = 0, 0%; group 2: <i>n</i> = 11, 15.7%; group 3: <i>n</i> = 10, 30.3%) (<i>p</i> = 0.012). Patients in group 3 had the higher rate of permanent pacemaker implantation (PPMI) (group 1: <i>n</i> = 1, 6.3%; group 2: <i>n</i> = 7, 10%; group 3: <i>n</i> = 9, 27.3%) (<i>p</i> = 0.012). In conclusion, ASCDS might help identify patients at higher risk of conduction disorders and PPMI requirement after TAVI.
ISSN:2077-0383